Venus Remedies Limited (BOM:526953)
1,066.80
+26.85 (2.58%)
At close: Apr 15, 2026
Venus Remedies Market Cap
Venus Remedies has a market cap or net worth of 13.89 billion as of April 16, 2026. Its market cap has increased by 249.87% in one year.
Market Cap
13.89B
Enterprise Value
11.68B
Revenue
7.03B
Ranking
n/a
PE Ratio
18.20
Stock Price
1,066.80
Market Cap Chart
Since October 19, 2004, Venus Remedies's market cap has increased from 242.83M to 13.89B, an increase of 5,619.83%. That is a compound annual growth rate of 20.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 13.89B | 35.48% |
| Dec 31, 2025 | 10.25B | 139.58% |
| Dec 31, 2024 | 4.28B | -21.14% |
| Dec 29, 2023 | 5.43B | 124.10% |
| Dec 30, 2022 | 2.42B | -55.77% |
| Dec 31, 2021 | 5.48B | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hikal | 22.58B |
| Morepen Laboratories | 21.98B |
| Kwality Pharmaceuticals | 15.55B |
| Amrutanjan Health Care | 15.18B |
| Shukra Pharmaceuticals | 14.20B |
| TTK Healthcare | 12.35B |
| Lincoln Pharmaceuticals | 11.54B |
| Fermenta Biotech | 9.59B |